Press Releases
         
 

July 26,2016

ITM gab heute bekannt, dass zwei Mitarbeiter des Tochterunternehmens ITG beim Transport von radioaktivem Abfall...

Gesamte Meldung

     
 

May 10,2016

ITM today announced that the EMA/CHMP has adopted a positive opinion for ITM's EndolucinBeta® (177Lutetium chloride)...

Full release

   PR ENB Positive Opinion  
 

March 24,2016

ITM Isotopen Technologien München AG (ITM) and Scil Proteins today announced they have entered into a partnership covering the field of targeted radio conjugates...

Full release

   Press Release March 24 2016  
 

March 7,2016

ITM Isotopen Technologien München AG (ITM) today announced that it has raised 20 million EUR in equity and plans to use the funds for further development of its promising radiopharmaceutical pipeline...

Full release

   Press Release March 7 2016  
 

August 20, 2015

Isotope Technologies Garching announces in-licensing of DOTA-Zoledronate for Bone Targeted Radionuclide Theranostics of Osseous Metastases. DOTA-Zoledronate specifically targets cancerous bone lesions and, when...

Full release
  ITG receives manufacturing authorization for Gallium-68 Generator  
 

January 12, 2015

ITG receives manufacturing authorization for pharmaceutical grade Ge-68/Ga-68 Generator. The approval by the regional government of Upper Bavaria came in December 2014, allowing ITG to...

Full release

  ITG receives manufacturing authorization for Gallium-68 Generator  
 

November 11, 2013

Endovascular Brachytherapy, itm Rhenium-PTA awarded CE mark. The superior treatment is indicated for restenosis prophylaxis utilizing high-energy, short-range Rhenium-188 for precise irradiation of restricted blood vessels.

Full release

  PR Endovascular Brachytherapy awarded CE mark  
 

September 18, 2013

Acquisition of exclusive manufacturing and marketing rights for DOTATOC

Full release

  PR Acquisition exclusive marketing rights DOTATOC